2[1]Jiang H, Chess L. An intergrated view of suppressor T cell subsets in immunoregulation. J Clin Invest,2004,114:1198-1208.
3[2]De Boer OJ, Hirsch F, van der Wal AC, et al. Costimulatory molecules in human atherosclerotic plaques: an indication of antigen specific T lymphocyte activation. Atherosclerosis, 1997,133:227-234.
4[3]Soejima H, Irie A, Miyamoto S, et al. Preference toward a T-helper type 1 response in patients with coronary spastic angina. Circulation,2003,107(17) :2196-2120.
5[4]Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med,1999,340:115-1261.
6[5]Shah PK. Plaque disruption and thrombosis: potential role of inflammation and infection. Cardiol Clin, 1999,17:270-281.
7[7]Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alphachains ( CD25 ). Breakdown of a single mechanism of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol, 1995,155( 1 ) :1151-1164.
8Sakaguchi S.Naturally arising FOXP3-expressing CD25^+CD4^+ regulatory T cells in immunological tolerance to self and non-self[J].Nat Immunol,2005,6(4):345
9Nishimura Eiji,Sakihama Toshiko,Setoguchi Ruka,et al.Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising FOXP3^+CD25^+ CD4^+ regulatory T cells[J].Int Immunol,2004,16(8):1189
10Chen ZH.A technique of cervical heterotopic heart transplantation in mice[J].Transplantation,1991,52(6):1099
3Arnolde L, Mcgrath B,Cocks M, et al. Adriamycin cardiomyopathy in the rabbit:an animal model of low output cardiac failure with activation of vasoconstrictor mechanisms [ J ]. Cardiovasc Res, 1985,191 ( 6 ) : 378 - 382.
4Cohen JL,Trenado A, Vasey D, et al. CD4 + CD25 + immune regulatory T cells: new therapeuties for graft-versus-host disease [ J ]. Exp Med, 2002,196(3) : 401 -406.
